multiplex
revers
transcriptionpolymeras
chain
reaction
mrtpcr
method
develop
simultan
detect
typingsubtyp
influenza
virus
b
respiratori
syncyti
virus
b
follow
dna
semiquantit
use
agil
bioanalyz
method
provid
rapid
specif
sensit
diagnost
tool
detect
semiquantif
respiratori
ill
specimen
acut
respiratori
tract
infect
ari
common
caus
morbid
mortal
young
children
elderli
immunecompromis
patient
worldwid
boivin
et
al
hinman
among
major
viral
caus
agent
ari
influenza
b
virus
respiratori
syncyti
virus
rsv
b
stockton
et
al
rapid
diagnosi
viral
pathogen
import
determin
appropri
clinic
intervent
monitor
relat
virus
outbreak
pandem
emerg
pathogen
number
techniqu
avail
detect
character
influenza
virus
rsv
includ
convent
method
cell
cultur
enzym
immunoassay
eia
immunofluoresc
recent
advanc
molecular
techniqu
enabl
detect
pathogen
base
nucleic
acid
sequenc
genet
materi
isol
virus
bacteria
clinic
specimen
notabl
polymeras
chain
reaction
pcr
base
molecular
method
use
wide
well
accept
laboratori
diagnosi
pathogen
due
rapid
sensit
high
throughput
capabl
fredrick
relman
louie
et
al
weinberg
et
al
yang
rothman
past
year
sever
multiplex
revers
transcriptionpolymeras
chain
reaction
mrtpcr
method
develop
detect
influenza
virus
rsv
parainfluenza
virus
piv
etc
bellaupujol
et
al
coira
et
al
grondahl
et
al
stockton
et
al
syrmi
et
al
method
analysi
pcr
product
reli
either
agaros
gel
electrophoresi
timeconsum
enzymelink
assay
mani
includ
nest
pcr
step
enhanc
sensit
howev
none
publish
method
provid
quantit
result
recent
realtim
rtpcr
assay
detect
influenza
rsv
develop
use
success
test
clinic
specimen
boivin
et
al
report
develop
rapid
specif
sensit
mrtpcr
method
simultan
detect
influenza
b
rsv
ab
primer
influenza
virus
select
nucleotid
sequenc
encod
hemagglutinin
ha
gene
follow
subtyp
f
r
subtyp
primer
influenza
b
virus
select
nucleotid
sequenc
encod
nucleoprotein
np
gene
follow
npf
npr
primer
rsv
select
nucleotid
sequenc
encod
nucleocapsid
protein
np
gene
follow
rsva
rsvanpf
rsvanpr
rsvb
rsvbnpf
rsvbnpr
pcr
assay
evalu
test
primer
pair
variou
laboratori
viru
stock
briefli
viral
rna
extract
l
influenza
rsv
viru
stock
respiratori
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
viral
particl
count
determin
electron
microscopi
advanc
biotechnolog
inc
columbia
md
previous
describ
hu
et
al
multiplex
rtpcr
carri
thermal
cycler
appli
biosystem
inc
foster
citi
ca
use
titan
one
tube
rtpcr
kit
roch
indianapoli
total
volum
l
l
rna
l
master
primer
mix
master
primer
mix
compris
l
l
l
b
l
rsva
l
rsvb
primer
includ
forward
revers
sequenc
stock
primer
concentr
ngml
pcr
program
c
min
c
min
c
min
follow
cycl
c
min
c
c
min
final
extens
carri
c
min
amplif
product
analyz
dna
labchip
use
agil
bioanalyz
accord
manufactur
instruct
agil
technolog
palo
alto
ca
briefli
l
pcr
reaction
load
one
sampl
well
labchip
contain
l
dna
marker
run
min
appropri
set
evalu
specif
sensit
follow
viru
stock
known
particl
number
use
posit
control
caledonia
ml
ml
bjohannesburg
ml
rsv
ml
rsv
ml
fig
show
dna
labchip
analysi
mrtpcr
product
variou
combin
virus
nonspecif
pcr
product
observ
addit
sensit
rtpcr
evalu
perform
pcr
duplic
type
viral
rna
independ
stock
minim
number
viral
particl
detect
assay
equival
b
rsv
rsv
b
respect
data
shown
mrtpcr
assay
util
evalu
nasal
swab
specimen
obtain
asian
children
month
old
respiratori
symptom
enrol
experiment
influenza
vaccin
trial
conduct
malaysia
singapor
thailand
india
winter
among
specimen
mrtpcr
detect
influenza
influenza
influenza
b
posit
rsv
ab
posit
sampl
tabl
wherea
cultur
confirm
identifi
influenza
influenza
b
posit
sampl
rsv
cultur
perform
specimen
pcr
detect
cultureposit
specimen
addit
benefit
distinguish
subtyp
addit
three
cultureneg
sampl
test
posit
mrtpcr
method
one
influenza
b
group
respect
despit
rel
small
sampl
size
valid
result
use
realtim
rtpcr
assay
perform
specimen
result
confirm
pcr
posit
show
compar
cultureposit
specimen
three
cultureneg
specimen
posit
pcr
contain
rel
low
copi
number
virus
rang
copi
per
reaction
data
shown
respiratori
virus
convent
diagnos
base
cell
cultur
antigen
detect
eia
timeconsum
limit
sensit
specif
although
realtim
pcr
may
higher
sensit
convent
pcr
latter
usual
econom
clinic
laboratori
equip
expens
realtim
pcr
instrument
addit
optim
multipl
realtim
pcr
current
limit
three
due
limit
number
fluorophor
cheng
unpublish
method
report
studi
primarili
target
influenza
b
virus
rsv
b
carri
singlestep
reaction
minim
opportun
contamin
sinc
secondari
tertiari
nest
pcr
need
previou
method
bellaupujol
et
al
coira
et
al
grondahl
et
al
stockton
et
al
pcr
amplicon
method
rang
bp
rel
small
size
increas
assay
sensit
analyz
pcr
product
dna
labchip
platform
agil
technolog
util
replac
convent
agaros
gel
electrophoresi
timeconsum
enzymelink
hybrid
assay
labchip
assay
consum
smaller
sampl
volum
l
per
reaction
also
enhanc
sensit
low
ng
l
dna
labchip
provid
unambigu
consist
semiquantit
result
permit
eas
qualiti
control
quantiti
estim
downstream
analysi
dna
sequenc
strain
determin
also
provid
inform
rel
abund
virus
case
mix
infect
result
show
mrtpcr
assay
could
easili
detect
specimen
contain
low
viru
copi
number
well
case
viru
coinfect
eg
case
instanc
b
detect
cultur
confirm
one
limit
method
size
pcr
product
rsv
b
distinguish
howev
separ
assay
design
address
limit
develop
later
hu
et
al
conclus
mrtpcr
provid
rapid
sensit
semiquantit
tool
detect
typingsubtyp
influenza
virus
rsv
appli
screen
respiratori
ill
specimen
obtain
patient
similar
clinic
respiratori
symptom
assay
easili
perform
local
laboratori
determin
caus
viral
agent
respiratori
ill
suspect
outbreak
newli
emerg
pathogen
sever
acut
respiratori
syndrom
sar
viru
potenti
avian
flu
viru
elimin
common
viral
pathogen
thu
facilit
local
diseas
manag
global
surveil
